1. Home
  2. CERS vs WEYS Comparison

CERS vs WEYS Comparison

Compare CERS & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • WEYS
  • Stock Information
  • Founded
  • CERS 1991
  • WEYS 1906
  • Country
  • CERS United States
  • WEYS United States
  • Employees
  • CERS N/A
  • WEYS N/A
  • Industry
  • CERS EDP Services
  • WEYS Apparel
  • Sector
  • CERS Technology
  • WEYS Consumer Staples
  • Exchange
  • CERS Nasdaq
  • WEYS Nasdaq
  • Market Cap
  • CERS 286.0M
  • WEYS 337.3M
  • IPO Year
  • CERS 1997
  • WEYS N/A
  • Fundamental
  • Price
  • CERS $1.81
  • WEYS $35.96
  • Analyst Decision
  • CERS Buy
  • WEYS
  • Analyst Count
  • CERS 3
  • WEYS 0
  • Target Price
  • CERS $3.17
  • WEYS N/A
  • AVG Volume (30 Days)
  • CERS 1.4M
  • WEYS 15.0K
  • Earning Date
  • CERS 03-04-2025
  • WEYS 03-04-2025
  • Dividend Yield
  • CERS N/A
  • WEYS 2.87%
  • EPS Growth
  • CERS N/A
  • WEYS N/A
  • EPS
  • CERS N/A
  • WEYS 3.02
  • Revenue
  • CERS $176,229,000.00
  • WEYS $290,409,000.00
  • Revenue This Year
  • CERS $21.42
  • WEYS N/A
  • Revenue Next Year
  • CERS $11.12
  • WEYS N/A
  • P/E Ratio
  • CERS N/A
  • WEYS $11.68
  • Revenue Growth
  • CERS 14.71
  • WEYS N/A
  • 52 Week Low
  • CERS $1.38
  • WEYS $27.05
  • 52 Week High
  • CERS $2.59
  • WEYS $41.05
  • Technical
  • Relative Strength Index (RSI)
  • CERS 57.20
  • WEYS 51.90
  • Support Level
  • CERS $1.74
  • WEYS $33.92
  • Resistance Level
  • CERS $1.87
  • WEYS $35.85
  • Average True Range (ATR)
  • CERS 0.10
  • WEYS 1.06
  • MACD
  • CERS 0.03
  • WEYS -0.07
  • Stochastic Oscillator
  • CERS 79.49
  • WEYS 48.24

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale and the North American retail segment. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

Share on Social Networks: